Ascendis Pharma A/S
TransCon technology platform for sustained-release therapeutic delivery
- Sector
- Biotech
- Headquarters
- HELLERUP, G7
- Latest Form D
- $60M, Dec 2014
- Total capital
- $60M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $60M
- 1 Form D · last Dec 2014
- 143 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 20
- 20 pending · first 2023
- Rank in peer group#52 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$60M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#52 · top 4%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Albert Wolff ChaDirectorNamed in SEC Form D filings
- Edwin Wolff de GraafDirectorNamed in SEC Form D filings
- Grethe Wolff RasmussenExecutive OfficerNamed in SEC Form D filings
- Harald Wolff RauExecutive OfficerNamed in SEC Form D filings
- James Wolff HealyDirectorNamed in SEC Form D filings
- Jan M?ller MikkelsenExecutive Officer, DirectorNamed in SEC Form D filings
Show all 14 people
- Jonathan Wolff SilversteinDirectorNamed in SEC Form D filings
- Lotte Wolff S?nderbjergExecutive OfficerNamed in SEC Form D filings
- Martin Wolff AusterExecutive OfficerNamed in SEC Form D filings
- Martin Wolff OlinDirectorNamed in SEC Form D filings
- Michael Wolff JensenExecutive Officer, DirectorNamed in SEC Form D filings
- Michael Wolff MayerDirectorNamed in SEC Form D filings
- Rafa?le Wolff TordjmanDirectorNamed in SEC Form D filings
- Thomas Wolff SolowayExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 20 granted of 40- New patentAuto Injector With Cartridge Locking SystemUSPTOUS 12,746,335
- PendingDegradable Hyaluronic Acid HydrogelsUSPTOApplication 19557593
- GrantedTreatment Of InfectionsUSPTOUS 12,648,997
Show all 40 patent records
- Auto Injector With Cartridge Locking SystemSep 29, 2026 · US 12,746,335Granted
- Degradable Hyaluronic Acid HydrogelsSep 17, 2026 · Application 19557593Pending
- Treatment Of InfectionsJun 9, 2026 · US 12,648,997Granted
- Degradable Hyaluronic Acid HydrogelsApr 7, 2026 · US 12,594,345Granted
- Auto Injector With Reconstitution Handling SupportMar 26, 2026 · Application 19407644Pending
- Drug Compounds Comprising Albumin-Binding MoietiesMar 12, 2026 · Application 19257318Pending
- Auto Injector With Reconstitution Handling SupportJan 6, 2026 · US 12,514,983Granted
- Methods Of Producing Hydrogel MicrospheresDec 25, 2025 · Application 19254990Pending
- Use Of Long-Acting Growth Hormone For Treating Inflammation-Induced DiseasesOct 2, 2025 · Application 18552656Pending
- Injector With CoverAug 26, 2025 · US D1,090,824Granted
- Hydrogel Cross-linked Hyaluronic Acid Prodrug Compositions And MethodsAug 14, 2025 · Application 19035168Pending
- Front Loaded Auto Injector For Administering A MedicamentAug 14, 2025 · Application 19174258Pending
- Auto Injector With Charger SafetyAug 12, 2025 · US 12,383,676Granted
- Auto Injector With Temperature ControlJul 24, 2025 · Application 19174102Pending
- Auto Injector With Charger SafetyJul 24, 2025 · Application 19174106Pending
- Auto Injector With Variable Plunger ForceJun 5, 2025 · Application 19052055Pending
- Auto Injector With Adaptable Air-shot MechanismMay 15, 2025 · Application 19022924Pending
- Auto Injector With Temperature ControlMay 13, 2025 · US 12,296,148Granted
- Front Loaded Auto Injector For Administering A MedicamentMay 6, 2025 · US 12,290,663Granted
- Prodrug Comprising A Drug-linker ConjugateApr 24, 2025 · Application 18920288Pending
- Auto Injector With Variable Plunger ForceMar 18, 2025 · US 12,251,541Granted
- Hydrogel Cross-linked Hyaluronic Acid Prodrug Compositions And MethodsMar 11, 2025 · US 12,246,070Granted
- Auto Injector With Adaptable Air-shot MechanismFeb 18, 2025 · US 12,226,616Granted
- Auto Injector With Measurement Of Battery Capacity Left Before Re-charging Is RequiredNov 14, 2024 · Application 18684567Pending
- Auto Injector With Detection Of Used Cartridge And Associated MethodAug 22, 2024 · Application 18652601Pending
- Auto Injector With Detection Of Used Cartridge And Associated MethodJun 11, 2024 · US 12,005,241Granted
- Auto Injector With Adaptable Air-shot MechanismApr 30, 2024 · US 11,969,581Granted
- Auto Injector With Reconstitution Handling SupportApr 16, 2024 · US 11,957,880Granted
- Conjugates Comprising Reversible Linkers And Uses ThereofMar 7, 2024 · Application 18105460Pending
- Conjugation Method for Carrier-Linked ProdrugsFeb 13, 2024 · US 11,896,671Granted
- Prodrug Comprising A Drug Linker ConjugateFeb 8, 2024 · Application 18479445Pending
- Auto Injector With Charger SafetyAug 29, 2023 · US 11,738,147Granted
- Hydrogel IrradiationAug 3, 2023 · Application 17923314Pending
- Auto Injector With Variable Plunger ForceJun 27, 2023 · US 11,684,724Granted
- Hydrogel Cross-linked Hyaluronic Acid Prodrug Compositions And MethodsMay 9, 2023 · US 11,642,415Granted
- Prodrugs Comprising an Aminoalkyl Glycine LinkerApr 25, 2023 · US 11,633,487Granted
- Biodegradable Polyethylene Glycol Based Water-Insoluble HydrogelsApr 20, 2023 · Application 18081106Pending
- Conjugates Undergoing Intramolecular RearrangementsApr 13, 2023 · Application 17790589Pending
- Front Loaded Auto Injector For Administering A MedicamentMar 21, 2023 · US 11,607,496Granted
- Auto Injector With Cartridge Locking SystemMar 9, 2023 · Application 17985438Pending
Related companies, and why
- Knopp Biosciences LLCSimilar federal contract value in Biotech · null in contracts
- Proxima Bio, Inc.Similar federal contract value in Biotech · null in contracts
- Mind Medicine (MindMed) Inc.Similar federal contract value in Biotech · null in contracts
- AbCellera Biologics Inc.Similar federal contract value in Biotech · null in contracts
- Cellares CorpSimilar federal contract value in Biotech · null in contracts
- Unicycive Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .